Ioannis Lamprou
Overview
Explore the profile of Ioannis Lamprou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
54
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mitrakas A, Kakouratos C, Lamprou I, Xanthopoulou E, Koukourakis M
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075700
Background/objectives: Non-small cell lung cancer (NSCLC) is a major cause of cancer-related deaths globally. The study focuses on understanding the interplay between genetic mutations, cancer stem cells (CSCs), and the...
2.
Xanthopoulou E, Lamprou I, Mitrakas A, Michos G, Zois C, Giatromanolaki A, et al.
Cancers (Basel)
. 2024 Oct;
16(19).
PMID: 39409895
Background/objectives: Immune checkpoint inhibitors have an established role in non-small cell lung cancer (NSCLC) therapy. The loss of HLA-class-I expression allows cancer cell evasion from immune surveillance, disease progression, and...
3.
Tsolou A, Koparanis D, Lamprou I, Giatromanolaki A, Koukourakis M
Int J Radiat Biol
. 2022 Aug;
99(4):692-701.
PMID: 35976051
Purpose: Lung cancer is considered as one of the most frequent malignancies worldwide. Radiotherapy is the main treatment modality applied for locally advanced disease, but remnant surviving cancer tissue results...
4.
Lamprou I, Kakouratos C, Tsolou A, Pavlidis P, Xanthopoulou E, Nanos C, et al.
Int J Radiat Oncol Biol Phys
. 2022 Feb;
113(2):401-414.
PMID: 35121129
Purpose: Radiation therapy is a principal treatment modality for localized and locally advanced prostate cancer (PCa). Metabolic alterations, including lipid metabolism, may reduce treatment efficacy, resulting in tumor relapse and...
5.
Kakouratos C, Kalamida D, Lamprou I, Xanthopoulou E, Nanos C, Giatromanolaki A, et al.
Br J Cancer
. 2021 Sep;
125(10):1377-1387.
PMID: 34471256
Introduction: The combination of radiotherapy with bicalutamide is the standard treatment of prostate cancer patients with high-risk or locally advanced disease. Whether new-generation anti-androgens, like apalutamide, can improve the radio-curability...
6.
Lamprou I, Tsolou A, Kakouratos C, Mitrakas A, Xanthopoulou E, Kassela K, et al.
Med Oncol
. 2021 Aug;
38(10):116.
PMID: 34410522
Lipid metabolism reprogramming is one of the adaptive events that drive tumor development and survival, and may account for resistance to chemotherapeutic drugs. Perilipins are structural proteins associated with lipophagy...
7.
Tsolou A, Lamprou I, Fortosi A, Liousia M, Giatromanolaki A, Koukourakis M
Life Sci
. 2019 Jun;
232:116562.
PMID: 31201845
Aims: Lung cancer is one of the main causes of cancer-related deaths worldwide and radiotherapy is a major treatment of choice. However, radioresistance is a main reason for radiotherapy failure...
8.
Koukourakis M, Tsolou A, Pouliliou S, Lamprou I, Papadopoulou M, Ilemosoglou M, et al.
Biochem Biophys Res Commun
. 2017 Jul;
491(4):932-938.
PMID: 28756228
Purpose: Up-regulation of lactate dehydrogenase LDHA, is a frequent event in human malignancies and relate to poor postoperative outcome. In the current study we examined the hypothesis that LDHA and...